Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a special diet soothe chemo nerve damage?

NCT ID NCT07365007

Recruiting now Symptom relief Sponsor: University of Michigan Rogel Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a diet low in added sugar, high in fiber, and rich in omega-3s (called LASO-3) can help reduce nerve pain, numbness, and tingling caused by chemotherapy. Fifty cancer survivors who finished chemo at least three months ago will receive virtual nutrition coaching from a dietitian. The main goal is to see if the program is practical and acceptable, not yet to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dietary intervention (low added sugar, high fiber, high omega-3)
What this could lead to
If it works, this could point toward a simple, non-drug way to manage nerve pain after chemotherapy.
What could go wrong
This is a small, early feasibility study with only 50 participants, so results may not apply to everyone. The diet requires significant lifestyle changes, and adherence may be low.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer chemotherapy-induced neuropathy hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM MALIGNANT SOLID NEOPLASM

Contacts and locations

Locations

  • University of Michigan Rogel Cancer Center

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.